Global LNP-mRNA Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global LNP-mRNA Therapy market size was valued at US$ 569 million in 2025 and is forecast to a readjusted size of US$ 823 million by 2032 with a CAGR of 5.5% during review period.
LNP-mRNA Therapy represents a cutting-edge biomedical technology that leverages the unique strengths of Lipid Nanoparticles (LNPs) and Messenger RNA (mRNA) to offer novel treatment avenues for various diseases. Serving as carriers, LNPs effectively shield mRNA from enzymatic degradation in the body and deliver it precisely to target cells. mRNA carries the genetic information necessary for synthesizing specific proteins; once inside cells, it directs the cells to produce these proteins, thereby triggering immune responses or repairing damaged tissues. This therapy demonstrates significant potential in treating cancers, genetic disorders, and infectious diseases. Its highly personalized and rapid-response characteristics have made LNP-mRNA Therapy a research focus in the biomedical field. By precisely regulating gene expression, LNP-mRNA Therapy provides patients with unprecedented treatment options, ushering in a new era of precision medicine.
The LNP-mRNA Therapy market is in a phase of rapid development. Following the successful application of COVID-19 vaccines, global R&D focus has expanded to areas such as cancer immunotherapy, rare genetic diseases, cardiovascular diseases, and regenerative medicine. With the optimization of intelligent delivery systems and the maturation of production processes, the market size is expected to maintain high growth over the next decade, driven by the needs of infectious disease control, large-scale data center-based vaccine production capabilities, investment in new energy medical technologies, and the trend towards precision medicine. Despite challenges such as cost, stability, and regulation, with policy support and capital investment in North America, Europe, and the Asia-Pacific region, LNP-mRNA technology is poised to become a core platform for next-generation biomedicine, driving the upgrading of the global pharmaceutical industry structure.
This report is a detailed and comprehensive analysis for global LNP-mRNA Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global LNP-mRNA Therapy market size and forecasts, in consumption value ($ Million), 2021-2032
Global LNP-mRNA Therapy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global LNP-mRNA Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global LNP-mRNA Therapy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
LNP-mRNA Therapy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe LNP-mRNA Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of LNP-mRNA Therapy, with revenue, gross margin, and global market share of LNP-mRNA Therapy from 2021 to 2026.
Chapter 3, the LNP-mRNA Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and LNP-mRNA Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of LNP-mRNA Therapy.
Chapter 13, to describe LNP-mRNA Therapy research findings and conclusion.
LNP-mRNA Therapy represents a cutting-edge biomedical technology that leverages the unique strengths of Lipid Nanoparticles (LNPs) and Messenger RNA (mRNA) to offer novel treatment avenues for various diseases. Serving as carriers, LNPs effectively shield mRNA from enzymatic degradation in the body and deliver it precisely to target cells. mRNA carries the genetic information necessary for synthesizing specific proteins; once inside cells, it directs the cells to produce these proteins, thereby triggering immune responses or repairing damaged tissues. This therapy demonstrates significant potential in treating cancers, genetic disorders, and infectious diseases. Its highly personalized and rapid-response characteristics have made LNP-mRNA Therapy a research focus in the biomedical field. By precisely regulating gene expression, LNP-mRNA Therapy provides patients with unprecedented treatment options, ushering in a new era of precision medicine.
The LNP-mRNA Therapy market is in a phase of rapid development. Following the successful application of COVID-19 vaccines, global R&D focus has expanded to areas such as cancer immunotherapy, rare genetic diseases, cardiovascular diseases, and regenerative medicine. With the optimization of intelligent delivery systems and the maturation of production processes, the market size is expected to maintain high growth over the next decade, driven by the needs of infectious disease control, large-scale data center-based vaccine production capabilities, investment in new energy medical technologies, and the trend towards precision medicine. Despite challenges such as cost, stability, and regulation, with policy support and capital investment in North America, Europe, and the Asia-Pacific region, LNP-mRNA technology is poised to become a core platform for next-generation biomedicine, driving the upgrading of the global pharmaceutical industry structure.
This report is a detailed and comprehensive analysis for global LNP-mRNA Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global LNP-mRNA Therapy market size and forecasts, in consumption value ($ Million), 2021-2032
Global LNP-mRNA Therapy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global LNP-mRNA Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global LNP-mRNA Therapy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
LNP-mRNA Therapy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Passive Targeting
- Active Targeting
- Vaccines
- Cancer Immunotherapy
- Genetic Disease Therapy
- Others
- Protein Replacement Therapy
- Immune Activation Therapy
- Gene Regulation Therapy
- Hospital
- Clinic
- Others
- Genevant Sciences
- Moderna
- BioNTech
- Pfizer
- NanoVation Therapeutics
- CureVac
- Sanofi
- Promab
- Grand Pharm
- Arcturus Therapeutics
- Synplogen
- CSPC
- Beijing JenKem Technology
- Starna Therapeutics
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe LNP-mRNA Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of LNP-mRNA Therapy, with revenue, gross margin, and global market share of LNP-mRNA Therapy from 2021 to 2026.
Chapter 3, the LNP-mRNA Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and LNP-mRNA Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of LNP-mRNA Therapy.
Chapter 13, to describe LNP-mRNA Therapy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of LNP-mRNA Therapy by Type
1.3.1 Overview: Global LNP-mRNA Therapy Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global LNP-mRNA Therapy Consumption Value Market Share by Type in 2025
1.3.3 Passive Targeting
1.3.4 Active Targeting
1.4 Classification of LNP-mRNA Therapy by Treatment Direction
1.4.1 Overview: Global LNP-mRNA Therapy Market Size by Treatment Direction: 2021 Versus 2025 Versus 2032
1.4.2 Global LNP-mRNA Therapy Consumption Value Market Share by Treatment Direction in 2025
1.4.3 Vaccines
1.4.4 Cancer Immunotherapy
1.4.5 Genetic Disease Therapy
1.4.6 Others
1.5 Classification of LNP-mRNA Therapy by Mechanisms of Action
1.5.1 Overview: Global LNP-mRNA Therapy Market Size by Mechanisms of Action: 2021 Versus 2025 Versus 2032
1.5.2 Global LNP-mRNA Therapy Consumption Value Market Share by Mechanisms of Action in 2025
1.5.3 Protein Replacement Therapy
1.5.4 Immune Activation Therapy
1.5.5 Gene Regulation Therapy
1.6 Global LNP-mRNA Therapy Market by Application
1.6.1 Overview: Global LNP-mRNA Therapy Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospital
1.6.3 Clinic
1.6.4 Others
1.7 Global LNP-mRNA Therapy Market Size & Forecast
1.8 Global LNP-mRNA Therapy Market Size and Forecast by Region
1.8.1 Global LNP-mRNA Therapy Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global LNP-mRNA Therapy Market Size by Region, (2021-2032)
1.8.3 North America LNP-mRNA Therapy Market Size and Prospect (2021-2032)
1.8.4 Europe LNP-mRNA Therapy Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific LNP-mRNA Therapy Market Size and Prospect (2021-2032)
1.8.6 South America LNP-mRNA Therapy Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa LNP-mRNA Therapy Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Genevant Sciences
2.1.1 Genevant Sciences Details
2.1.2 Genevant Sciences Major Business
2.1.3 Genevant Sciences LNP-mRNA Therapy Product and Solutions
2.1.4 Genevant Sciences LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Genevant Sciences Recent Developments and Future Plans
2.2 Moderna
2.2.1 Moderna Details
2.2.2 Moderna Major Business
2.2.3 Moderna LNP-mRNA Therapy Product and Solutions
2.2.4 Moderna LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Moderna Recent Developments and Future Plans
2.3 BioNTech
2.3.1 BioNTech Details
2.3.2 BioNTech Major Business
2.3.3 BioNTech LNP-mRNA Therapy Product and Solutions
2.3.4 BioNTech LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 BioNTech Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer LNP-mRNA Therapy Product and Solutions
2.4.4 Pfizer LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 NanoVation Therapeutics
2.5.1 NanoVation Therapeutics Details
2.5.2 NanoVation Therapeutics Major Business
2.5.3 NanoVation Therapeutics LNP-mRNA Therapy Product and Solutions
2.5.4 NanoVation Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 NanoVation Therapeutics Recent Developments and Future Plans
2.6 CureVac
2.6.1 CureVac Details
2.6.2 CureVac Major Business
2.6.3 CureVac LNP-mRNA Therapy Product and Solutions
2.6.4 CureVac LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 CureVac Recent Developments and Future Plans
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi LNP-mRNA Therapy Product and Solutions
2.7.4 Sanofi LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Sanofi Recent Developments and Future Plans
2.8 Promab
2.8.1 Promab Details
2.8.2 Promab Major Business
2.8.3 Promab LNP-mRNA Therapy Product and Solutions
2.8.4 Promab LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Promab Recent Developments and Future Plans
2.9 Grand Pharm
2.9.1 Grand Pharm Details
2.9.2 Grand Pharm Major Business
2.9.3 Grand Pharm LNP-mRNA Therapy Product and Solutions
2.9.4 Grand Pharm LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Grand Pharm Recent Developments and Future Plans
2.10 Arcturus Therapeutics
2.10.1 Arcturus Therapeutics Details
2.10.2 Arcturus Therapeutics Major Business
2.10.3 Arcturus Therapeutics LNP-mRNA Therapy Product and Solutions
2.10.4 Arcturus Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Arcturus Therapeutics Recent Developments and Future Plans
2.11 Synplogen
2.11.1 Synplogen Details
2.11.2 Synplogen Major Business
2.11.3 Synplogen LNP-mRNA Therapy Product and Solutions
2.11.4 Synplogen LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Synplogen Recent Developments and Future Plans
2.12 CSPC
2.12.1 CSPC Details
2.12.2 CSPC Major Business
2.12.3 CSPC LNP-mRNA Therapy Product and Solutions
2.12.4 CSPC LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 CSPC Recent Developments and Future Plans
2.13 Beijing JenKem Technology
2.13.1 Beijing JenKem Technology Details
2.13.2 Beijing JenKem Technology Major Business
2.13.3 Beijing JenKem Technology LNP-mRNA Therapy Product and Solutions
2.13.4 Beijing JenKem Technology LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Beijing JenKem Technology Recent Developments and Future Plans
2.14 Starna Therapeutics
2.14.1 Starna Therapeutics Details
2.14.2 Starna Therapeutics Major Business
2.14.3 Starna Therapeutics LNP-mRNA Therapy Product and Solutions
2.14.4 Starna Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Starna Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global LNP-mRNA Therapy Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of LNP-mRNA Therapy by Company Revenue
3.2.2 Top 3 LNP-mRNA Therapy Players Market Share in 2025
3.2.3 Top 6 LNP-mRNA Therapy Players Market Share in 2025
3.3 LNP-mRNA Therapy Market: Overall Company Footprint Analysis
3.3.1 LNP-mRNA Therapy Market: Region Footprint
3.3.2 LNP-mRNA Therapy Market: Company Product Type Footprint
3.3.3 LNP-mRNA Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global LNP-mRNA Therapy Consumption Value and Market Share by Type (2021-2026)
4.2 Global LNP-mRNA Therapy Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global LNP-mRNA Therapy Consumption Value Market Share by Application (2021-2026)
5.2 Global LNP-mRNA Therapy Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America LNP-mRNA Therapy Consumption Value by Type (2021-2032)
6.2 North America LNP-mRNA Therapy Market Size by Application (2021-2032)
6.3 North America LNP-mRNA Therapy Market Size by Country
6.3.1 North America LNP-mRNA Therapy Consumption Value by Country (2021-2032)
6.3.2 United States LNP-mRNA Therapy Market Size and Forecast (2021-2032)
6.3.3 Canada LNP-mRNA Therapy Market Size and Forecast (2021-2032)
6.3.4 Mexico LNP-mRNA Therapy Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe LNP-mRNA Therapy Consumption Value by Type (2021-2032)
7.2 Europe LNP-mRNA Therapy Consumption Value by Application (2021-2032)
7.3 Europe LNP-mRNA Therapy Market Size by Country
7.3.1 Europe LNP-mRNA Therapy Consumption Value by Country (2021-2032)
7.3.2 Germany LNP-mRNA Therapy Market Size and Forecast (2021-2032)
7.3.3 France LNP-mRNA Therapy Market Size and Forecast (2021-2032)
7.3.4 United Kingdom LNP-mRNA Therapy Market Size and Forecast (2021-2032)
7.3.5 Russia LNP-mRNA Therapy Market Size and Forecast (2021-2032)
7.3.6 Italy LNP-mRNA Therapy Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific LNP-mRNA Therapy Consumption Value by Type (2021-2032)
8.2 Asia-Pacific LNP-mRNA Therapy Consumption Value by Application (2021-2032)
8.3 Asia-Pacific LNP-mRNA Therapy Market Size by Region
8.3.1 Asia-Pacific LNP-mRNA Therapy Consumption Value by Region (2021-2032)
8.3.2 China LNP-mRNA Therapy Market Size and Forecast (2021-2032)
8.3.3 Japan LNP-mRNA Therapy Market Size and Forecast (2021-2032)
8.3.4 South Korea LNP-mRNA Therapy Market Size and Forecast (2021-2032)
8.3.5 India LNP-mRNA Therapy Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia LNP-mRNA Therapy Market Size and Forecast (2021-2032)
8.3.7 Australia LNP-mRNA Therapy Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America LNP-mRNA Therapy Consumption Value by Type (2021-2032)
9.2 South America LNP-mRNA Therapy Consumption Value by Application (2021-2032)
9.3 South America LNP-mRNA Therapy Market Size by Country
9.3.1 South America LNP-mRNA Therapy Consumption Value by Country (2021-2032)
9.3.2 Brazil LNP-mRNA Therapy Market Size and Forecast (2021-2032)
9.3.3 Argentina LNP-mRNA Therapy Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa LNP-mRNA Therapy Consumption Value by Type (2021-2032)
10.2 Middle East & Africa LNP-mRNA Therapy Consumption Value by Application (2021-2032)
10.3 Middle East & Africa LNP-mRNA Therapy Market Size by Country
10.3.1 Middle East & Africa LNP-mRNA Therapy Consumption Value by Country (2021-2032)
10.3.2 Turkey LNP-mRNA Therapy Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia LNP-mRNA Therapy Market Size and Forecast (2021-2032)
10.3.4 UAE LNP-mRNA Therapy Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 LNP-mRNA Therapy Market Drivers
11.2 LNP-mRNA Therapy Market Restraints
11.3 LNP-mRNA Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 LNP-mRNA Therapy Industry Chain
12.2 LNP-mRNA Therapy Upstream Analysis
12.3 LNP-mRNA Therapy Midstream Analysis
12.4 LNP-mRNA Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of LNP-mRNA Therapy by Type
1.3.1 Overview: Global LNP-mRNA Therapy Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global LNP-mRNA Therapy Consumption Value Market Share by Type in 2025
1.3.3 Passive Targeting
1.3.4 Active Targeting
1.4 Classification of LNP-mRNA Therapy by Treatment Direction
1.4.1 Overview: Global LNP-mRNA Therapy Market Size by Treatment Direction: 2021 Versus 2025 Versus 2032
1.4.2 Global LNP-mRNA Therapy Consumption Value Market Share by Treatment Direction in 2025
1.4.3 Vaccines
1.4.4 Cancer Immunotherapy
1.4.5 Genetic Disease Therapy
1.4.6 Others
1.5 Classification of LNP-mRNA Therapy by Mechanisms of Action
1.5.1 Overview: Global LNP-mRNA Therapy Market Size by Mechanisms of Action: 2021 Versus 2025 Versus 2032
1.5.2 Global LNP-mRNA Therapy Consumption Value Market Share by Mechanisms of Action in 2025
1.5.3 Protein Replacement Therapy
1.5.4 Immune Activation Therapy
1.5.5 Gene Regulation Therapy
1.6 Global LNP-mRNA Therapy Market by Application
1.6.1 Overview: Global LNP-mRNA Therapy Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospital
1.6.3 Clinic
1.6.4 Others
1.7 Global LNP-mRNA Therapy Market Size & Forecast
1.8 Global LNP-mRNA Therapy Market Size and Forecast by Region
1.8.1 Global LNP-mRNA Therapy Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global LNP-mRNA Therapy Market Size by Region, (2021-2032)
1.8.3 North America LNP-mRNA Therapy Market Size and Prospect (2021-2032)
1.8.4 Europe LNP-mRNA Therapy Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific LNP-mRNA Therapy Market Size and Prospect (2021-2032)
1.8.6 South America LNP-mRNA Therapy Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa LNP-mRNA Therapy Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Genevant Sciences
2.1.1 Genevant Sciences Details
2.1.2 Genevant Sciences Major Business
2.1.3 Genevant Sciences LNP-mRNA Therapy Product and Solutions
2.1.4 Genevant Sciences LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Genevant Sciences Recent Developments and Future Plans
2.2 Moderna
2.2.1 Moderna Details
2.2.2 Moderna Major Business
2.2.3 Moderna LNP-mRNA Therapy Product and Solutions
2.2.4 Moderna LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Moderna Recent Developments and Future Plans
2.3 BioNTech
2.3.1 BioNTech Details
2.3.2 BioNTech Major Business
2.3.3 BioNTech LNP-mRNA Therapy Product and Solutions
2.3.4 BioNTech LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 BioNTech Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer LNP-mRNA Therapy Product and Solutions
2.4.4 Pfizer LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 NanoVation Therapeutics
2.5.1 NanoVation Therapeutics Details
2.5.2 NanoVation Therapeutics Major Business
2.5.3 NanoVation Therapeutics LNP-mRNA Therapy Product and Solutions
2.5.4 NanoVation Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 NanoVation Therapeutics Recent Developments and Future Plans
2.6 CureVac
2.6.1 CureVac Details
2.6.2 CureVac Major Business
2.6.3 CureVac LNP-mRNA Therapy Product and Solutions
2.6.4 CureVac LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 CureVac Recent Developments and Future Plans
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi LNP-mRNA Therapy Product and Solutions
2.7.4 Sanofi LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Sanofi Recent Developments and Future Plans
2.8 Promab
2.8.1 Promab Details
2.8.2 Promab Major Business
2.8.3 Promab LNP-mRNA Therapy Product and Solutions
2.8.4 Promab LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Promab Recent Developments and Future Plans
2.9 Grand Pharm
2.9.1 Grand Pharm Details
2.9.2 Grand Pharm Major Business
2.9.3 Grand Pharm LNP-mRNA Therapy Product and Solutions
2.9.4 Grand Pharm LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Grand Pharm Recent Developments and Future Plans
2.10 Arcturus Therapeutics
2.10.1 Arcturus Therapeutics Details
2.10.2 Arcturus Therapeutics Major Business
2.10.3 Arcturus Therapeutics LNP-mRNA Therapy Product and Solutions
2.10.4 Arcturus Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Arcturus Therapeutics Recent Developments and Future Plans
2.11 Synplogen
2.11.1 Synplogen Details
2.11.2 Synplogen Major Business
2.11.3 Synplogen LNP-mRNA Therapy Product and Solutions
2.11.4 Synplogen LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Synplogen Recent Developments and Future Plans
2.12 CSPC
2.12.1 CSPC Details
2.12.2 CSPC Major Business
2.12.3 CSPC LNP-mRNA Therapy Product and Solutions
2.12.4 CSPC LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 CSPC Recent Developments and Future Plans
2.13 Beijing JenKem Technology
2.13.1 Beijing JenKem Technology Details
2.13.2 Beijing JenKem Technology Major Business
2.13.3 Beijing JenKem Technology LNP-mRNA Therapy Product and Solutions
2.13.4 Beijing JenKem Technology LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Beijing JenKem Technology Recent Developments and Future Plans
2.14 Starna Therapeutics
2.14.1 Starna Therapeutics Details
2.14.2 Starna Therapeutics Major Business
2.14.3 Starna Therapeutics LNP-mRNA Therapy Product and Solutions
2.14.4 Starna Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Starna Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global LNP-mRNA Therapy Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of LNP-mRNA Therapy by Company Revenue
3.2.2 Top 3 LNP-mRNA Therapy Players Market Share in 2025
3.2.3 Top 6 LNP-mRNA Therapy Players Market Share in 2025
3.3 LNP-mRNA Therapy Market: Overall Company Footprint Analysis
3.3.1 LNP-mRNA Therapy Market: Region Footprint
3.3.2 LNP-mRNA Therapy Market: Company Product Type Footprint
3.3.3 LNP-mRNA Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global LNP-mRNA Therapy Consumption Value and Market Share by Type (2021-2026)
4.2 Global LNP-mRNA Therapy Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global LNP-mRNA Therapy Consumption Value Market Share by Application (2021-2026)
5.2 Global LNP-mRNA Therapy Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America LNP-mRNA Therapy Consumption Value by Type (2021-2032)
6.2 North America LNP-mRNA Therapy Market Size by Application (2021-2032)
6.3 North America LNP-mRNA Therapy Market Size by Country
6.3.1 North America LNP-mRNA Therapy Consumption Value by Country (2021-2032)
6.3.2 United States LNP-mRNA Therapy Market Size and Forecast (2021-2032)
6.3.3 Canada LNP-mRNA Therapy Market Size and Forecast (2021-2032)
6.3.4 Mexico LNP-mRNA Therapy Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe LNP-mRNA Therapy Consumption Value by Type (2021-2032)
7.2 Europe LNP-mRNA Therapy Consumption Value by Application (2021-2032)
7.3 Europe LNP-mRNA Therapy Market Size by Country
7.3.1 Europe LNP-mRNA Therapy Consumption Value by Country (2021-2032)
7.3.2 Germany LNP-mRNA Therapy Market Size and Forecast (2021-2032)
7.3.3 France LNP-mRNA Therapy Market Size and Forecast (2021-2032)
7.3.4 United Kingdom LNP-mRNA Therapy Market Size and Forecast (2021-2032)
7.3.5 Russia LNP-mRNA Therapy Market Size and Forecast (2021-2032)
7.3.6 Italy LNP-mRNA Therapy Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific LNP-mRNA Therapy Consumption Value by Type (2021-2032)
8.2 Asia-Pacific LNP-mRNA Therapy Consumption Value by Application (2021-2032)
8.3 Asia-Pacific LNP-mRNA Therapy Market Size by Region
8.3.1 Asia-Pacific LNP-mRNA Therapy Consumption Value by Region (2021-2032)
8.3.2 China LNP-mRNA Therapy Market Size and Forecast (2021-2032)
8.3.3 Japan LNP-mRNA Therapy Market Size and Forecast (2021-2032)
8.3.4 South Korea LNP-mRNA Therapy Market Size and Forecast (2021-2032)
8.3.5 India LNP-mRNA Therapy Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia LNP-mRNA Therapy Market Size and Forecast (2021-2032)
8.3.7 Australia LNP-mRNA Therapy Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America LNP-mRNA Therapy Consumption Value by Type (2021-2032)
9.2 South America LNP-mRNA Therapy Consumption Value by Application (2021-2032)
9.3 South America LNP-mRNA Therapy Market Size by Country
9.3.1 South America LNP-mRNA Therapy Consumption Value by Country (2021-2032)
9.3.2 Brazil LNP-mRNA Therapy Market Size and Forecast (2021-2032)
9.3.3 Argentina LNP-mRNA Therapy Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa LNP-mRNA Therapy Consumption Value by Type (2021-2032)
10.2 Middle East & Africa LNP-mRNA Therapy Consumption Value by Application (2021-2032)
10.3 Middle East & Africa LNP-mRNA Therapy Market Size by Country
10.3.1 Middle East & Africa LNP-mRNA Therapy Consumption Value by Country (2021-2032)
10.3.2 Turkey LNP-mRNA Therapy Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia LNP-mRNA Therapy Market Size and Forecast (2021-2032)
10.3.4 UAE LNP-mRNA Therapy Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 LNP-mRNA Therapy Market Drivers
11.2 LNP-mRNA Therapy Market Restraints
11.3 LNP-mRNA Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 LNP-mRNA Therapy Industry Chain
12.2 LNP-mRNA Therapy Upstream Analysis
12.3 LNP-mRNA Therapy Midstream Analysis
12.4 LNP-mRNA Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global LNP-mRNA Therapy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global LNP-mRNA Therapy Consumption Value by Treatment Direction, (USD Million), 2021 & 2025 & 2032
Table 3. Global LNP-mRNA Therapy Consumption Value by Mechanisms of Action, (USD Million), 2021 & 2025 & 2032
Table 4. Global LNP-mRNA Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global LNP-mRNA Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global LNP-mRNA Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Genevant Sciences Company Information, Head Office, and Major Competitors
Table 8. Genevant Sciences Major Business
Table 9. Genevant Sciences LNP-mRNA Therapy Product and Solutions
Table 10. Genevant Sciences LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Genevant Sciences Recent Developments and Future Plans
Table 12. Moderna Company Information, Head Office, and Major Competitors
Table 13. Moderna Major Business
Table 14. Moderna LNP-mRNA Therapy Product and Solutions
Table 15. Moderna LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Moderna Recent Developments and Future Plans
Table 17. BioNTech Company Information, Head Office, and Major Competitors
Table 18. BioNTech Major Business
Table 19. BioNTech LNP-mRNA Therapy Product and Solutions
Table 20. BioNTech LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Pfizer Company Information, Head Office, and Major Competitors
Table 22. Pfizer Major Business
Table 23. Pfizer LNP-mRNA Therapy Product and Solutions
Table 24. Pfizer LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Pfizer Recent Developments and Future Plans
Table 26. NanoVation Therapeutics Company Information, Head Office, and Major Competitors
Table 27. NanoVation Therapeutics Major Business
Table 28. NanoVation Therapeutics LNP-mRNA Therapy Product and Solutions
Table 29. NanoVation Therapeutics LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. NanoVation Therapeutics Recent Developments and Future Plans
Table 31. CureVac Company Information, Head Office, and Major Competitors
Table 32. CureVac Major Business
Table 33. CureVac LNP-mRNA Therapy Product and Solutions
Table 34. CureVac LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. CureVac Recent Developments and Future Plans
Table 36. Sanofi Company Information, Head Office, and Major Competitors
Table 37. Sanofi Major Business
Table 38. Sanofi LNP-mRNA Therapy Product and Solutions
Table 39. Sanofi LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Sanofi Recent Developments and Future Plans
Table 41. Promab Company Information, Head Office, and Major Competitors
Table 42. Promab Major Business
Table 43. Promab LNP-mRNA Therapy Product and Solutions
Table 44. Promab LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Promab Recent Developments and Future Plans
Table 46. Grand Pharm Company Information, Head Office, and Major Competitors
Table 47. Grand Pharm Major Business
Table 48. Grand Pharm LNP-mRNA Therapy Product and Solutions
Table 49. Grand Pharm LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Grand Pharm Recent Developments and Future Plans
Table 51. Arcturus Therapeutics Company Information, Head Office, and Major Competitors
Table 52. Arcturus Therapeutics Major Business
Table 53. Arcturus Therapeutics LNP-mRNA Therapy Product and Solutions
Table 54. Arcturus Therapeutics LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Arcturus Therapeutics Recent Developments and Future Plans
Table 56. Synplogen Company Information, Head Office, and Major Competitors
Table 57. Synplogen Major Business
Table 58. Synplogen LNP-mRNA Therapy Product and Solutions
Table 59. Synplogen LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Synplogen Recent Developments and Future Plans
Table 61. CSPC Company Information, Head Office, and Major Competitors
Table 62. CSPC Major Business
Table 63. CSPC LNP-mRNA Therapy Product and Solutions
Table 64. CSPC LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. CSPC Recent Developments and Future Plans
Table 66. Beijing JenKem Technology Company Information, Head Office, and Major Competitors
Table 67. Beijing JenKem Technology Major Business
Table 68. Beijing JenKem Technology LNP-mRNA Therapy Product and Solutions
Table 69. Beijing JenKem Technology LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Beijing JenKem Technology Recent Developments and Future Plans
Table 71. Starna Therapeutics Company Information, Head Office, and Major Competitors
Table 72. Starna Therapeutics Major Business
Table 73. Starna Therapeutics LNP-mRNA Therapy Product and Solutions
Table 74. Starna Therapeutics LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Starna Therapeutics Recent Developments and Future Plans
Table 76. Global LNP-mRNA Therapy Revenue (USD Million) by Players (2021-2026)
Table 77. Global LNP-mRNA Therapy Revenue Share by Players (2021-2026)
Table 78. Breakdown of LNP-mRNA Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 79. Market Position of Players in LNP-mRNA Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 80. Head Office of Key LNP-mRNA Therapy Players
Table 81. LNP-mRNA Therapy Market: Company Product Type Footprint
Table 82. LNP-mRNA Therapy Market: Company Product Application Footprint
Table 83. LNP-mRNA Therapy New Market Entrants and Barriers to Market Entry
Table 84. LNP-mRNA Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 85. Global LNP-mRNA Therapy Consumption Value (USD Million) by Type (2021-2026)
Table 86. Global LNP-mRNA Therapy Consumption Value Share by Type (2021-2026)
Table 87. Global LNP-mRNA Therapy Consumption Value Forecast by Type (2027-2032)
Table 88. Global LNP-mRNA Therapy Consumption Value by Application (2021-2026)
Table 89. Global LNP-mRNA Therapy Consumption Value Forecast by Application (2027-2032)
Table 90. North America LNP-mRNA Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 91. North America LNP-mRNA Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 92. North America LNP-mRNA Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 93. North America LNP-mRNA Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 94. North America LNP-mRNA Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 95. North America LNP-mRNA Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 96. Europe LNP-mRNA Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 97. Europe LNP-mRNA Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 98. Europe LNP-mRNA Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 99. Europe LNP-mRNA Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 100. Europe LNP-mRNA Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 101. Europe LNP-mRNA Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Asia-Pacific LNP-mRNA Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 103. Asia-Pacific LNP-mRNA Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 104. Asia-Pacific LNP-mRNA Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Asia-Pacific LNP-mRNA Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Asia-Pacific LNP-mRNA Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 107. Asia-Pacific LNP-mRNA Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 108. South America LNP-mRNA Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 109. South America LNP-mRNA Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 110. South America LNP-mRNA Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 111. South America LNP-mRNA Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 112. South America LNP-mRNA Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 113. South America LNP-mRNA Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Middle East & Africa LNP-mRNA Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 115. Middle East & Africa LNP-mRNA Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 116. Middle East & Africa LNP-mRNA Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 117. Middle East & Africa LNP-mRNA Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 118. Middle East & Africa LNP-mRNA Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 119. Middle East & Africa LNP-mRNA Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 120. Global Key Players of LNP-mRNA Therapy Upstream (Raw Materials)
Table 121. Global LNP-mRNA Therapy Typical Customers
Table 1. Global LNP-mRNA Therapy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global LNP-mRNA Therapy Consumption Value by Treatment Direction, (USD Million), 2021 & 2025 & 2032
Table 3. Global LNP-mRNA Therapy Consumption Value by Mechanisms of Action, (USD Million), 2021 & 2025 & 2032
Table 4. Global LNP-mRNA Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global LNP-mRNA Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global LNP-mRNA Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Genevant Sciences Company Information, Head Office, and Major Competitors
Table 8. Genevant Sciences Major Business
Table 9. Genevant Sciences LNP-mRNA Therapy Product and Solutions
Table 10. Genevant Sciences LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Genevant Sciences Recent Developments and Future Plans
Table 12. Moderna Company Information, Head Office, and Major Competitors
Table 13. Moderna Major Business
Table 14. Moderna LNP-mRNA Therapy Product and Solutions
Table 15. Moderna LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Moderna Recent Developments and Future Plans
Table 17. BioNTech Company Information, Head Office, and Major Competitors
Table 18. BioNTech Major Business
Table 19. BioNTech LNP-mRNA Therapy Product and Solutions
Table 20. BioNTech LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Pfizer Company Information, Head Office, and Major Competitors
Table 22. Pfizer Major Business
Table 23. Pfizer LNP-mRNA Therapy Product and Solutions
Table 24. Pfizer LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Pfizer Recent Developments and Future Plans
Table 26. NanoVation Therapeutics Company Information, Head Office, and Major Competitors
Table 27. NanoVation Therapeutics Major Business
Table 28. NanoVation Therapeutics LNP-mRNA Therapy Product and Solutions
Table 29. NanoVation Therapeutics LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. NanoVation Therapeutics Recent Developments and Future Plans
Table 31. CureVac Company Information, Head Office, and Major Competitors
Table 32. CureVac Major Business
Table 33. CureVac LNP-mRNA Therapy Product and Solutions
Table 34. CureVac LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. CureVac Recent Developments and Future Plans
Table 36. Sanofi Company Information, Head Office, and Major Competitors
Table 37. Sanofi Major Business
Table 38. Sanofi LNP-mRNA Therapy Product and Solutions
Table 39. Sanofi LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Sanofi Recent Developments and Future Plans
Table 41. Promab Company Information, Head Office, and Major Competitors
Table 42. Promab Major Business
Table 43. Promab LNP-mRNA Therapy Product and Solutions
Table 44. Promab LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Promab Recent Developments and Future Plans
Table 46. Grand Pharm Company Information, Head Office, and Major Competitors
Table 47. Grand Pharm Major Business
Table 48. Grand Pharm LNP-mRNA Therapy Product and Solutions
Table 49. Grand Pharm LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Grand Pharm Recent Developments and Future Plans
Table 51. Arcturus Therapeutics Company Information, Head Office, and Major Competitors
Table 52. Arcturus Therapeutics Major Business
Table 53. Arcturus Therapeutics LNP-mRNA Therapy Product and Solutions
Table 54. Arcturus Therapeutics LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Arcturus Therapeutics Recent Developments and Future Plans
Table 56. Synplogen Company Information, Head Office, and Major Competitors
Table 57. Synplogen Major Business
Table 58. Synplogen LNP-mRNA Therapy Product and Solutions
Table 59. Synplogen LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Synplogen Recent Developments and Future Plans
Table 61. CSPC Company Information, Head Office, and Major Competitors
Table 62. CSPC Major Business
Table 63. CSPC LNP-mRNA Therapy Product and Solutions
Table 64. CSPC LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. CSPC Recent Developments and Future Plans
Table 66. Beijing JenKem Technology Company Information, Head Office, and Major Competitors
Table 67. Beijing JenKem Technology Major Business
Table 68. Beijing JenKem Technology LNP-mRNA Therapy Product and Solutions
Table 69. Beijing JenKem Technology LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Beijing JenKem Technology Recent Developments and Future Plans
Table 71. Starna Therapeutics Company Information, Head Office, and Major Competitors
Table 72. Starna Therapeutics Major Business
Table 73. Starna Therapeutics LNP-mRNA Therapy Product and Solutions
Table 74. Starna Therapeutics LNP-mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Starna Therapeutics Recent Developments and Future Plans
Table 76. Global LNP-mRNA Therapy Revenue (USD Million) by Players (2021-2026)
Table 77. Global LNP-mRNA Therapy Revenue Share by Players (2021-2026)
Table 78. Breakdown of LNP-mRNA Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 79. Market Position of Players in LNP-mRNA Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 80. Head Office of Key LNP-mRNA Therapy Players
Table 81. LNP-mRNA Therapy Market: Company Product Type Footprint
Table 82. LNP-mRNA Therapy Market: Company Product Application Footprint
Table 83. LNP-mRNA Therapy New Market Entrants and Barriers to Market Entry
Table 84. LNP-mRNA Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 85. Global LNP-mRNA Therapy Consumption Value (USD Million) by Type (2021-2026)
Table 86. Global LNP-mRNA Therapy Consumption Value Share by Type (2021-2026)
Table 87. Global LNP-mRNA Therapy Consumption Value Forecast by Type (2027-2032)
Table 88. Global LNP-mRNA Therapy Consumption Value by Application (2021-2026)
Table 89. Global LNP-mRNA Therapy Consumption Value Forecast by Application (2027-2032)
Table 90. North America LNP-mRNA Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 91. North America LNP-mRNA Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 92. North America LNP-mRNA Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 93. North America LNP-mRNA Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 94. North America LNP-mRNA Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 95. North America LNP-mRNA Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 96. Europe LNP-mRNA Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 97. Europe LNP-mRNA Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 98. Europe LNP-mRNA Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 99. Europe LNP-mRNA Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 100. Europe LNP-mRNA Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 101. Europe LNP-mRNA Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Asia-Pacific LNP-mRNA Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 103. Asia-Pacific LNP-mRNA Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 104. Asia-Pacific LNP-mRNA Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Asia-Pacific LNP-mRNA Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Asia-Pacific LNP-mRNA Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 107. Asia-Pacific LNP-mRNA Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 108. South America LNP-mRNA Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 109. South America LNP-mRNA Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 110. South America LNP-mRNA Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 111. South America LNP-mRNA Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 112. South America LNP-mRNA Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 113. South America LNP-mRNA Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Middle East & Africa LNP-mRNA Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 115. Middle East & Africa LNP-mRNA Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 116. Middle East & Africa LNP-mRNA Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 117. Middle East & Africa LNP-mRNA Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 118. Middle East & Africa LNP-mRNA Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 119. Middle East & Africa LNP-mRNA Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 120. Global Key Players of LNP-mRNA Therapy Upstream (Raw Materials)
Table 121. Global LNP-mRNA Therapy Typical Customers
LIST OF FIGURES
Figure 1. LNP-mRNA Therapy Picture
Figure 2. Global LNP-mRNA Therapy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global LNP-mRNA Therapy Consumption Value Market Share by Type in 2025
Figure 4. Passive Targeting
Figure 5. Active Targeting
Figure 6. Global LNP-mRNA Therapy Consumption Value by Treatment Direction, (USD Million), 2021 & 2025 & 2032
Figure 7. Global LNP-mRNA Therapy Consumption Value Market Share by Treatment Direction in 2025
Figure 8. Vaccines
Figure 9. Cancer Immunotherapy
Figure 10. Genetic Disease Therapy
Figure 11. Others
Figure 12. Global LNP-mRNA Therapy Consumption Value by Mechanisms of Action, (USD Million), 2021 & 2025 & 2032
Figure 13. Global LNP-mRNA Therapy Consumption Value Market Share by Mechanisms of Action in 2025
Figure 14. Protein Replacement Therapy
Figure 15. Immune Activation Therapy
Figure 16. Gene Regulation Therapy
Figure 17. Global LNP-mRNA Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. LNP-mRNA Therapy Consumption Value Market Share by Application in 2025
Figure 19. Hospital Picture
Figure 20. Clinic Picture
Figure 21. Others Picture
Figure 22. Global LNP-mRNA Therapy Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global LNP-mRNA Therapy Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market LNP-mRNA Therapy Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global LNP-mRNA Therapy Consumption Value Market Share by Region (2021-2032)
Figure 26. Global LNP-mRNA Therapy Consumption Value Market Share by Region in 2025
Figure 27. North America LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 30. South America LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global LNP-mRNA Therapy Revenue Share by Players in 2025
Figure 34. LNP-mRNA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of LNP-mRNA Therapy by Player Revenue in 2025
Figure 36. Top 3 LNP-mRNA Therapy Players Market Share in 2025
Figure 37. Top 6 LNP-mRNA Therapy Players Market Share in 2025
Figure 38. Global LNP-mRNA Therapy Consumption Value Share by Type (2021-2026)
Figure 39. Global LNP-mRNA Therapy Market Share Forecast by Type (2027-2032)
Figure 40. Global LNP-mRNA Therapy Consumption Value Share by Application (2021-2026)
Figure 41. Global LNP-mRNA Therapy Market Share Forecast by Application (2027-2032)
Figure 42. North America LNP-mRNA Therapy Consumption Value Market Share by Type (2021-2032)
Figure 43. North America LNP-mRNA Therapy Consumption Value Market Share by Application (2021-2032)
Figure 44. North America LNP-mRNA Therapy Consumption Value Market Share by Country (2021-2032)
Figure 45. United States LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe LNP-mRNA Therapy Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe LNP-mRNA Therapy Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe LNP-mRNA Therapy Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 52. France LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific LNP-mRNA Therapy Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific LNP-mRNA Therapy Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific LNP-mRNA Therapy Consumption Value Market Share by Region (2021-2032)
Figure 59. China LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 62. India LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 65. South America LNP-mRNA Therapy Consumption Value Market Share by Type (2021-2032)
Figure 66. South America LNP-mRNA Therapy Consumption Value Market Share by Application (2021-2032)
Figure 67. South America LNP-mRNA Therapy Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa LNP-mRNA Therapy Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa LNP-mRNA Therapy Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa LNP-mRNA Therapy Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 76. LNP-mRNA Therapy Market Drivers
Figure 77. LNP-mRNA Therapy Market Restraints
Figure 78. LNP-mRNA Therapy Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. LNP-mRNA Therapy Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source
Figure 1. LNP-mRNA Therapy Picture
Figure 2. Global LNP-mRNA Therapy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global LNP-mRNA Therapy Consumption Value Market Share by Type in 2025
Figure 4. Passive Targeting
Figure 5. Active Targeting
Figure 6. Global LNP-mRNA Therapy Consumption Value by Treatment Direction, (USD Million), 2021 & 2025 & 2032
Figure 7. Global LNP-mRNA Therapy Consumption Value Market Share by Treatment Direction in 2025
Figure 8. Vaccines
Figure 9. Cancer Immunotherapy
Figure 10. Genetic Disease Therapy
Figure 11. Others
Figure 12. Global LNP-mRNA Therapy Consumption Value by Mechanisms of Action, (USD Million), 2021 & 2025 & 2032
Figure 13. Global LNP-mRNA Therapy Consumption Value Market Share by Mechanisms of Action in 2025
Figure 14. Protein Replacement Therapy
Figure 15. Immune Activation Therapy
Figure 16. Gene Regulation Therapy
Figure 17. Global LNP-mRNA Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. LNP-mRNA Therapy Consumption Value Market Share by Application in 2025
Figure 19. Hospital Picture
Figure 20. Clinic Picture
Figure 21. Others Picture
Figure 22. Global LNP-mRNA Therapy Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global LNP-mRNA Therapy Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market LNP-mRNA Therapy Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global LNP-mRNA Therapy Consumption Value Market Share by Region (2021-2032)
Figure 26. Global LNP-mRNA Therapy Consumption Value Market Share by Region in 2025
Figure 27. North America LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 30. South America LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global LNP-mRNA Therapy Revenue Share by Players in 2025
Figure 34. LNP-mRNA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of LNP-mRNA Therapy by Player Revenue in 2025
Figure 36. Top 3 LNP-mRNA Therapy Players Market Share in 2025
Figure 37. Top 6 LNP-mRNA Therapy Players Market Share in 2025
Figure 38. Global LNP-mRNA Therapy Consumption Value Share by Type (2021-2026)
Figure 39. Global LNP-mRNA Therapy Market Share Forecast by Type (2027-2032)
Figure 40. Global LNP-mRNA Therapy Consumption Value Share by Application (2021-2026)
Figure 41. Global LNP-mRNA Therapy Market Share Forecast by Application (2027-2032)
Figure 42. North America LNP-mRNA Therapy Consumption Value Market Share by Type (2021-2032)
Figure 43. North America LNP-mRNA Therapy Consumption Value Market Share by Application (2021-2032)
Figure 44. North America LNP-mRNA Therapy Consumption Value Market Share by Country (2021-2032)
Figure 45. United States LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe LNP-mRNA Therapy Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe LNP-mRNA Therapy Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe LNP-mRNA Therapy Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 52. France LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific LNP-mRNA Therapy Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific LNP-mRNA Therapy Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific LNP-mRNA Therapy Consumption Value Market Share by Region (2021-2032)
Figure 59. China LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 62. India LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 65. South America LNP-mRNA Therapy Consumption Value Market Share by Type (2021-2032)
Figure 66. South America LNP-mRNA Therapy Consumption Value Market Share by Application (2021-2032)
Figure 67. South America LNP-mRNA Therapy Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa LNP-mRNA Therapy Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa LNP-mRNA Therapy Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa LNP-mRNA Therapy Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 76. LNP-mRNA Therapy Market Drivers
Figure 77. LNP-mRNA Therapy Market Restraints
Figure 78. LNP-mRNA Therapy Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. LNP-mRNA Therapy Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source
